Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir最新文献_第2页

Uric Acid/Albumin Ratio: Beyond Risk Stratification to Therapeutic Guidance in Hypertension. 尿酸/白蛋白比：超越危险分层到高血压的治疗指导。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.83913

Ali Sezgin, Veysel Ozan Tanık, Bülent Özlek

引用次数: 0

Suppression of Recurrent Ventricular Fibrillation Associated with J-Wave Syndrome Using Cilostazol. 西洛他唑抑制与j波综合征相关的复发性心室颤动。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.48409

Uğur Canpolat, Kudret Aytemir

引用次数: 0

Artificial Intelligence in Cardiac Rehabilitation: Assessing ChatGPT's Knowledge and Clinical Scenario Responses-Uncorrected Proof. 心脏康复中的人工智能：评估ChatGPT的知识和临床情景反应-未纠正的证据。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.39289

Tuğba Çetin

引用次数: 0

New Drugs for Resistant Hypertension: Pending Issue? 治疗顽固性高血压的新药：悬而未决的问题？

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.74304

Francesco Fici, Nicolas Roberto Robles, Istemihan Tengiz, Guido Grassi

引用次数: 0

Reply to the Letter to the Editor: 'Uric Acid/Albumin Ratio: Beyond Risk Stratification to Therapeutic Guidance in Hypertension'. 回复给编辑的信：“尿酸/白蛋白比率：超越风险分层到高血压治疗指导”。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.30971

Burcunur Karayiğit, Orhan Karayiğit, Ahmet Balun, Hamdi Temel

引用次数: 0

Association Between Right Ventricular Echocardiographic Parameters and HFA-PEFF Score in Heart Failure with Preserved Ejection Fraction. 保留射血分数的心力衰竭患者右心室超声心动图参数与HFA-PEFF评分的关系。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.25905

Hacı Ali Kürklü, Türkan Seda Tan, Nil Özyüncü, Kerim Esenboğa, İrem Dinçer

{"title":"Association Between Right Ventricular Echocardiographic Parameters and HFA-PEFF Score in Heart Failure with Preserved Ejection Fraction.","authors":"Hacı Ali Kürklü, Türkan Seda Tan, Nil Özyüncü, Kerim Esenboğa, İrem Dinçer","doi":"10.5543/tkda.2025.25905","DOIUrl":"https://doi.org/10.5543/tkda.2025.25905","url":null,"abstract":"Objective: Heart failure with preserved ejection fraction (HFpEF) is a leading clinical syndrome, accounting for more than 50% of hospitalizations due to heart failure. The HFA-PEFF algorithm, used for the diagnosis of HFpEF, also has prognostic value. The primary purpose of this work was to explore the relationship between the HFA-PEFF score and right ventricular (RV) echocardiographic parameters.Methods: 127 patients diagnosed with HFpEF between January 2021 and November 2024, with adequate transthoracic echocardiography (TTE) images, were retrospectively evaluated. Patients were categorized into three prognostic risk groups based on their HFA-PEFF scores: low (0-2), intermediate (3-4) and high (5-6). RV function was assessed using Tricuspid annular plane systolic excursion (TAPSE), tricuspid annular S' velocity and RV free wall longitudinal strain (RVFW GLS). The relationship between the HFA-PEFF score and RV parameters was evaluated using One-way ANOVA and Spearman correlation analysis.Results: Patients with high HFA-PEFF scores showed significant deterioration in TAPSE and RV GLS values. A moderate negative correlation was observed between HFA-PEFF score and RVFW GLS (r = 0.50, P < 0.001), while a mild negative correlation was found with TAPSE (r = -0.35, P < 0.001).Conclusion: In HFpEF patients with poor prognosis as identified by the HFA-PEFF score, there was a marked deterioration in RV parameters, particularly RVFW 2D GLS and TAPSE. These findings suggest that incorporating RV parameters into HFpEF diagnostic and prognostic algorithms might provide additional clinical value.","PeriodicalId":94261,"journal":{"name":"Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144586038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Entrapment of a Multipolar Mapping Catheter in a Mitral Valve Prosthesis-Uncorrected Proof. 在二尖瓣假体中夹持多极定位导管-未校正证明。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.22678

Serkan Çay, Meryem Kara, Sona Huseyinova, İlke Erbay, Özcan Özeke, Elif Hande Özcan Çetin, Ahmet Korkmaz, Fırat Özcan, Serkan Topaloğlu

引用次数: 0

Left Anterior Descending Artery to Right Coronary Artery Bifurcation Stenting with Culotte Technique in Acute Inferior Myocardial Infarction. 左前降支至右冠状动脉分叉支架术治疗急性下壁心肌梗死。

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2024.77257

Murat Akçay, Ahmet Çınar, Aydın Can Ulusoy, Fatma Rumeysa Karaçeşme, Metin Çoksevim

引用次数: 0

The HALP Score's Prognostic Value for the Elderly (≥75 years) Patients Following Percutaneous Coronary Intervention for Acute Myocardial Infarction. HALP评分对老年（≥75岁）急性心肌梗死经皮冠状动脉介入治疗患者的预后价值

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2025.45606

Cemalettin Yılmaz, İsmail Üngan, Enes Arslan, Emrah Çitil, Ömer Uluuysal, Muhammet Mücahit Tiryaki, Doğan Şen, Ahmet Karaduman, Regayip Zehir

{"title":"The HALP Score's Prognostic Value for the Elderly (≥75 years) Patients Following Percutaneous Coronary Intervention for Acute Myocardial Infarction.","authors":"Cemalettin Yılmaz, İsmail Üngan, Enes Arslan, Emrah Çitil, Ömer Uluuysal, Muhammet Mücahit Tiryaki, Doğan Şen, Ahmet Karaduman, Regayip Zehir","doi":"10.5543/tkda.2025.45606","DOIUrl":"https://doi.org/10.5543/tkda.2025.45606","url":null,"abstract":"Objective: Despite the fact that percutaneous coronary intervention (PCI) lowers mortality following acute myocardial infarction (AMI), older patients (≥75 years) are still at high risk of mortality. The purpose of this study was to evaluate the prognostic significance of the HALP score, which reflects the inflammatory and nutritional status, in this population.Method: We retrospectively included 128 elderly patients who had PCI at our institution between 2019 and 2022. The primary endpoint of the study was long-term all-cause mortality. The study population was categorized into two distinct groups based on survival status: survivors and non-survivors. A multivariable Cox regression analysis was conducted to identify independent predictors of long-term all-cause mortality.Results: The median follow-up time was 49.9 (35.6-62.74) months. In multivariable analysis, the HALP score and CRP independently predicted all-cause mortality at long-term follow-up (hazard ratio (HR): 0.96, 95% confidence interval (CI): 0.94-0.99, p=0.003; HR: 1.04, 95% CI: 1.01-1.07, p=0.020; respectively). Receiver operating characteristic curve analysis identified 26.252 as the optimal HALP score cut-off for predicting mortality (area under the curve (AUC): 0.764; 95% CI: 0.672-0.855; p< 0.001), with 73% sensitivity and 70.3% specificity. The HALP score demonstrated a higher AUC value, indicating better discriminative power compared to its individual components. In Kaplan-Meier analysis, patients with HALP score< 26.252 had a greater follow-up death (log rank p< 0.0001).Conclusion: The HALP score is an independent predictor of long-term all-cause death in older AMI patients following PCI.","PeriodicalId":94261,"journal":{"name":"Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144586047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Dilemma of Edoxaban Interruption and Heparin Bridging Before Upgrading to Cardiac Resynchronization Therapy in an Older Patient with Atrial Fibrillation, Chronic Kidney Disease, and Mitral Bioprosthesis. 老年心房颤动、慢性肾病和二尖瓣生物假体患者在升级到心脏再同步化治疗前，edo沙班中断和肝素桥接的困境

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Pub Date : 2025-07-07 DOI: 10.5543/tkda.2024.86907

Mert Doğan, Uğur Canpolat

{"title":"The Dilemma of Edoxaban Interruption and Heparin Bridging Before Upgrading to Cardiac Resynchronization Therapy in an Older Patient with Atrial Fibrillation, Chronic Kidney Disease, and Mitral Bioprosthesis.","authors":"Mert Doğan, Uğur Canpolat","doi":"10.5543/tkda.2024.86907","DOIUrl":"https://doi.org/10.5543/tkda.2024.86907","url":null,"abstract":"The peri-procedural management of novel oral anticoagulants (NOAC) should be individualized based on the patient (age, body weight, renal function, medications, previous thromboembolic/bleeding event, presence of prosthetic valve) and procedural (bleeding risk) characteristics. Less invasive procedures carry a relatively low bleeding risk and may be performed under minimally- or uninterrupted NOAC therapy. However, upgrading from implantable cardioverter defibrillator (ICD) to cardiac resynchronization therapy (CRT) is more complex than the initial implantation procedure. Thus, the timing of the last NOAC intake before an elective procedure requires judgment based on the individual benefit/risk ratio. Herein, we presented the management of an elderly patient with atrial fibrillation, grade IIIb chronic renal disease, low body weight, and bioprosthetic mitral valve who underwent upgrading from ICD to CRT-D procedure, experienced a bioprosthetic valve thrombosis 24 hours after an interruption of edoxaban therapy without heparin bridging, and successfully treated with ultraslow tPA therapy.","PeriodicalId":94261,"journal":{"name":"Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0